Alprenolol-d7 hydrochloride(Synonyms: (RS)-Alprenolol-d7 hydrochloride; dl-Alprenolol-d7(hydrochloride))

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Alprenolol-d7 hydrochloride (Synonyms: (RS)-Alprenolol-d7 hydrochloride; dl-Alprenolol-d7(hydrochloride))

Alprenolol-d7 ((RS)-Alprenolol-d7) hydrochloride 是 Alprenolol hydrochloride 的氘代物。Alprenolol盐酸盐是一个非选择性的beta阻断剂,也是5-HT1A受体的拮抗剂。

Alprenolol-d7 hydrochloride(Synonyms: (RS)-Alprenolol-d7 hydrochloride;  dl-Alprenolol-d7(hydrochloride))

Alprenolol-d7 hydrochloride Chemical Structure

CAS No. : 2714410-80-5

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Alprenolol-d7 ((RS)-Alprenolol-d7) hydrochloride is the deuterium labeled Alprenolol hydrochloride. Alprenolol hydrochloride is a non-selective beta blocker as well as 5-HT1A receptor antagonist.

体外研究
(In Vitro)

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

292.85

Formula

C15H17D7ClNO2

CAS 号

2714410-80-5

中文名称

盐酸阿普洛尔 d7 (盐酸盐)

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

    [2]. Schreiber R et al. Involvement of 5-HT1A receptors in the anxiolytic action of S 14671 in the pigeon conflict test. Pharmacol Biochem Behav. 1995 Jun-Jul;51(2-3):211-5.

    [3]. Millan MJ et al. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists. J Pharmacol Exp Ther, 1994 Jan, 268(1):337-52.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务